Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Supports comprehensive stroke prevention beyond polypill; leaves open optimal integration of lifestyle and socioeconomic interventions in trials.
Thirty years of clinical trials have demonstrated that stroke can be prevented by reducing blood pressure to less than 140/90 mm Hg or by a further decrease of 10/5 mm Hg when blood pressure is controlled, by reducing LDL cholesterol by at least 1 mmol/l (39 mg/dl), and by inhibiting platelet aggregation. The (too simplistic) concept of the polypill strategy combining pharmacologic agents to achieve these goals is supposed to reduce the risk by 80% overall. However, reducing general salt and sugar intake, giving up smoking, developing prevention clinics with prevention nurses to improve adherence to preventive treatments, as well as decreasing poverty and malnutrition, increasing the level of hygiene, fighting against infectious diseases and financially helping developing countries are all combined necessary approaches to decrease the worldwide burden of stroke and other vascular diseases.
No takes yet. Share an insight, caveat, or question.
Pierre Amarenco (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: